Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Keyword index :: pre bis ret :: REMPI - reproduction hivernale renal failure

Items for "renal failure"

Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients

Background: Ghrelin is an endogenous hormone expressed predominantly in the stomach...

Keywords: cholesterol, ghrelin, Polymorphism, renal failure

09/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Atrial natriuretic peptide and related peptides

In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases...

Keywords: Acute coronary syndrome, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), Heart failure, renal failure

10/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiency

Background: The lecithin:cholesterol acyltransferase (LCAT) gene is located on the long arm of chromosome 16 and encodes a highly conserved enzyme that catalyzes the formation of most plasma lipoprotein cholesteryl esters...

Keywords: chromosome 16, corneal opacity, LCAT deficiency, LCAT gene mutation, lecithin:cholesterol acyltransferase (LCAT), renal failure

04/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Analytical and clinical performance of three natriuretic peptide tests in the emergency room

Background: The aim of the present study was to investigate the analytical and diagnostic utility of B-type natriuretic peptide (BNP) and the N-terminus of this prohormone, N-terminal pro-BNP (NT-pro-BNP) testing in the emergency department to identify acute congestive heart failure (CHF).

Methods: A blood sample taken from patients presenting to the emergency department with acute dyspnoea (n=80) was analyzed for natriuretic peptides using three different assays [Triage BNP (Biosite), Centaur BNP (Bayer) and Elecsys NT-pro-BNP (Roche)]...

Keywords: diagnosis, dyspnoea, Heart failure, natriuretic peptides, renal failure

05/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation

Hyperhomocysteinaemia almost invariably occurs in patients with end-stage renal disease (ESRD), but there is debate whether, within the group of ESRD patients, higher or lower plasma homocysteine concentrations are related to an increased risk of vascular disease...

Keywords: hyperhomocysteinaemia, renal failure, sulphur amino acid metabolism, transmethylation

10/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates

Plasma cystatin C, a new marker of glomerular filtration rate (GFR), was prospectively evaluated in surgical intensive care...

Keywords: biochemical marker, Intensive Care, renal failure

09/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Clinical relevance of non-cardiac determinants of natriuretic peptide levels

There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides) plasma concentration may be elevated in many clinical conditions besides cardiovascular diseases, the most frequent being lung diseases, renal and liver failure, acute cerebrovascular events, acute and chronic inflammatory diseases and certain metabolic and endocrine disorders...

Keywords: diagnostic accuracy, Heart failure, natriuretic peptides, renal failure

11/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants

Aim: To analyze the side effects of captopril, an angiotensin converting enzyme inhibitor (ACEI) in newborn and young infants.

Methods: Retrospective analysis of side effects in 43 patients with congenital heart disease after cardiac surgery treated with captopril for heart failure during a two-year period.

Results: Median age of the patients was 26 days (range 6–310 days), median weight 3.5 kg (range 1.9–7.9 kg)...

Keywords: Angiotensin converting enzyme inhibitor, Heart failure, hypotension, infant, Newborn, renal failure

09/2008 | Journal of Perinatal Medicine, Walter de Gruyter